News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Insilico Medicine (03696.HK) and Yuanqi Bio Expand AI-Driven R&D Collaboration Involving Up to USD94.75 Million
Insilico Medicine (03696.HK) announced that it has reached an expanded AI-driven R&D collaboration with the commercial biopharmaceutical company Yuanqi Bio. Through this collaborat...
Reset
Send
The window will close in 5 seconds
Insilico Medicine (03696.HK) and Yuanqi Bio Expand AI-Driven R&D Collaboration Involving Up to USD94.75 Million
Close
Recommend
5
Positive
7
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Insilico Medicine (03696.HK)  -3.550 (-5.839%)    Short selling $54.48M; Ratio 67.797%   announced that it has reached an expanded AI-driven R&D collaboration with the commercial biopharmaceutical company Yuanqi Bio. Through this collaboration, the two parties aim to provide broader and more precise treatment solutions for highly challenging neurological diseases, thereby reducing late-stage R&D risks and enhancing potential clinical benefits.

The two parties will utilize generative AI to jointly develop an innovative candidate molecule with specific attributes targeting challenging neurological diseases and advance it to the preclinical candidate (PCC) stage to meet differentiated clinical needs. The total transaction amount for this expanded collaboration could reach up to USD94.75 million. Insilico Medicine is expected to receive upfront payments and milestone payments from Yuanqi Bio. (ca/u)
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Related News Insilico Medicine (03696.HK) Annual Loss Widens Sharply to USD352 Million



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.